Urokinase Therapy in Diabetic Foot Syndrome

NCT00537498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot
Arterial Occlusive Disease
Ischemia

Interventions

DRUG: Urokinase

Sponsor

medac GmbH